Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species
- PMID: 19606228
- PMCID: PMC2707620
- DOI: 10.1371/journal.pone.0006263
Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species
Abstract
Background: Mycobacterium indicus pranii (MIP), popularly known as Mw, is a cultivable, non-pathogenic organism, which, based on its growth and metabolic properties, is classified in Runyon Group IV along with M. fortuitum, M. smegmatis and M. vaccae. The novelty of this bacterium was accredited to its immunological ability to undergo antigen driven blast transformation of leukocytes and delayed hypersensitivity skin test in leprosy patients, a disease endemic in the Indian sub-continent. Consequently, MIP has been extensively evaluated for its biochemical and immunological properties leading to its usage as an immunomodulator in leprosy and tuberculosis patients. However, owing to advances in sequencing and culture techniques, the citing of new strains with almost 100% similarity in the sequences of marker genes like 16S rRNA, has compromised the identity of MIP as a novel species. Hence, to define its precise taxonomic position, we have carried out polyphasic taxonomic studies on MIP that integrate its phenotypic, chemotaxonomic and molecular phylogenetic attributes.
Methodology/principal findings: The comparative analysis of 16S rRNA sequence of MIP by using BLAST algorithm at NCBI (nr database) revealed a similarity of > or =99% with M. intracellulare, M. arosiense, M. chimaera, M. seoulense, M. avium subsp. hominissuis, M. avium subsp. paratuberculosis and M. bohemicum. Further analysis with other widely used markers like rpoB and hsp65 could resolve the phylogenetic relationship between MIP and other closely related mycobacteria apart from M. intracellulare and M. chimaera, which shares > or =99% similarity with corresponding MIP orthologues. Molecular phylogenetic analysis, based on the concatenation of candidate orthologues of 16S rRNA, hsp65 and rpoB, also substantiated its distinctiveness from all the related organisms used in the analysis excluding M. intracellulare and M. chimaera with which it exhibited a close proximity. This necessitated further analysis of MIP with more sensitive and segregating parameters to ascertain its precise taxonomic position as a new species. The analysis of MIP and its comparison with other mycobacterial reference strains based on cellular and biochemical features, growth characteristics and chemotaxonomic studies like FAME profiling confirmed that MIP is uniquely endowed with diverse metabolic attributes that effectively distinguishes it from all the closely related mycobacteria including M. intracellulare and M. chimaera.
Conclusion: The results presented in this study coupled with the non-pathogenic nature and different biochemical and immunomodulatory properties of MIP affirm it as a distinct species belonging to M. avium complex (MAC). It is further proposed to use an earlier suggested name Mycobacterium indicus pranii for this newly established mycobacterial species. This study also exemplifies the growing need for a uniform, consensus based broader polyphasic frame work for the purpose of taxonomy and speciation, particularly in the genus Mycobacterium.
Conflict of interest statement
Figures


Similar articles
-
Comparative analyses of nonpathogenic, opportunistic, and totally pathogenic mycobacteria reveal genomic and biochemical variabilities and highlight the survival attributes of Mycobacterium tuberculosis.mBio. 2014 Nov 4;5(6):e02020. doi: 10.1128/mBio.02020-14. mBio. 2014. PMID: 25370496 Free PMC article.
-
Molecular analysis of clinical isolates previously diagnosed as Mycobacterium intracellulare reveals incidental findings of "Mycobacterium indicus pranii" genotypes in human lung infection.BMC Infect Dis. 2015 Sep 30;15:406. doi: 10.1186/s12879-015-1140-4. BMC Infect Dis. 2015. PMID: 26423052 Free PMC article.
-
Raman spectroscopy reveals distinct differences between two closely related bacterial strains, Mycobacterium indicus pranii and Mycobacterium intracellulare.Anal Bioanal Chem. 2019 Dec;411(30):7997-8009. doi: 10.1007/s00216-019-02197-z. Epub 2019 Nov 16. Anal Bioanal Chem. 2019. PMID: 31732785
-
[Bacteriology of mycobacteria: taxonomic and morphological characteristics].Nihon Rinsho. 1998 Dec;56(12):3001-7. Nihon Rinsho. 1998. PMID: 9883600 Review. Japanese.
-
Mycobacterium Indicus Pranii (MIP) Vaccine: Pharmacology, Indication, Dosing Schedules, Administration, and Side Effects in Clinical Practice.Indian Dermatol Online J. 2023 Oct 17;14(6):753-761. doi: 10.4103/idoj.idoj_360_23. eCollection 2023 Nov-Dec. Indian Dermatol Online J. 2023. PMID: 38099011 Free PMC article. Review.
Cited by
-
Reply to '"Mycobacterium indicus pranii" is a strain of Mycobacterium intracellulare': "M. indicus pranii" is a distinct strain, not derived from M. intracellulare, and is an organism at an evolutionary transition point between a fast grower and slow grower.mBio. 2015 Apr 7;6(2):e00352-15. doi: 10.1128/mBio.00352-15. mBio. 2015. PMID: 25852162 Free PMC article. No abstract available.
-
Assessing the hazard of death, cardiac tamponade, and pericardial constriction among HIV and tuberculosis pericarditis patients using the extended Cox-hazard model: Intervention study.Health Sci Rep. 2024 Feb 14;7(2):e1892. doi: 10.1002/hsr2.1892. eCollection 2024 Feb. Health Sci Rep. 2024. PMID: 38361809 Free PMC article.
-
Therapeutic Vaccines for Tuberculosis: An Overview.Front Immunol. 2022 Jun 24;13:878471. doi: 10.3389/fimmu.2022.878471. eCollection 2022. Front Immunol. 2022. PMID: 35812462 Free PMC article. Review.
-
Mycobacterium indicus pranii supernatant induces apoptotic cell death in mouse peritoneal macrophages in vitro.PLoS One. 2011 Feb 11;6(2):e17093. doi: 10.1371/journal.pone.0017093. PLoS One. 2011. PMID: 21347304 Free PMC article.
-
Virulence and immune response induced by Mycobacterium avium complex strains in a model of progressive pulmonary tuberculosis and subcutaneous infection in BALB/c mice.Infect Immun. 2013 Nov;81(11):4001-12. doi: 10.1128/IAI.00150-13. Epub 2013 Aug 19. Infect Immun. 2013. PMID: 23959717 Free PMC article.
References
-
- Talwar GP. Towards development of a vaccine against leprosy. Lepr Ind. 1978;50:492–497. - PubMed
-
- Talwar GP, Zaheer SA, Mukherjee R, Walia R, Misra RS, et al. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients. Vaccine. 1990;8:121–129. - PubMed
-
- Yadava A, Suresh NR, Zaheer SA, Talwar GP, Mukherjee R. T-Cell responses to fractionated antigens of Mycobacterium w, a candidate anti-leprosy vaccine, in leprosy patients. Scand J Immunol. 1991;34:23–31. - PubMed
-
- Zaheer SA, Mukherjee R, Ramkumar B, Misra RS, Sharma AK, et al. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy. J Infect Dis. 1993;167:401–410. - PubMed
-
- Sharma P, Mukherjee R, Talwar GP, Sarathchandra KG, Walia R, et al. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8–10 years. Lepr Rev. 2005;76:127–143. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Research Materials